SOLIGENIX INC (SNGX)
US8342236044 - Common Stock
Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Announces Participation at the Spartan Capital Investor Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Soligenix Announces Participation at the Spartan Capital Investor Conference
Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference...
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Invited to Present at Upcoming Investor Conferences
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Announces Partnership with Sterling Pharma Solutions
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Receives European Patent for Improved Production of Synthetic Hypericin
/PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial Results
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
7 Top Stocks Under $10: July 2024 Edition
There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!
5 Investors Betting Big on Soligenix (SNGX) Stock
SNGX stock is elevating higher after Soligenix released positive results from its HyBryte study. Here are the company's top investors.
Why Is uniQure (QURE) Stock Up 51% Today?
UniQure stock is up on Tuesday as QURE investors react to positive clinical trial data for its Huntington’s Disease treatment candidate.
Why Is Soligenix (SNGX) Stock Up 296% Today?
Soligenix stock is up on Tuesday with heavy trading of SNGX shares alongside positive clinical trial data from the company.